LSA
PACB icon

Leonteq Securities AG’s Pacific Biosciences PACB Stock Holding History

Leonteq Securities AG’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-644
Closed -$882 – 1255
2024
Q2 		$882 Hold
644
– – ﹤0.01% 1135
2024
Q1 		$2.42K Hold
644
– – ﹤0.01% 1125
2023
Q4 		$6.32K Hold
644
– – ﹤0.01% 1031
2023
Q3 		$5.38K Hold
644
– – ﹤0.01% 1058
2023
Q2 		$8.56K Sell
644
-9,418
-94% -$114K ﹤0.01% 1060
2023
Q1 		$117K Hold
10,062
– – 0.01% 626
2022
Q4 		$82.3K Sell
10,062
-5,798
-37% -$50K ﹤0.01% 709
2022
Q3 		$92.1K Sell
15,860
-1,741
-10% -$9.99K ﹤0.01% 659
2022
Q2 		$77.8K Buy
17,601
+16,957
+2,633% +$103K ﹤0.01% 732
2022
Q1 		$5.86K Hold
644
– – ﹤0.01% 1156
2021
Q4 		$13.2K Hold
644
– – ﹤0.01% 1130
2021
Q3 		$16.5K Hold
644
– – ﹤0.01% 1014
2021
Q2 		$22.5K Hold
644
– – ﹤0.01% 934
2021
Q1 		$21.5K Buy
+644
New +$22.5K ﹤0.01% 878

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Leonteq Securities AG's PACB Position: Q3 2024 in Review

Leonteq Securities AG sold out of Pacific Biosciences (PACB) in Q3 2024, closing a stake of 644 shares — an estimated $882 sold.

Leonteq Securities AG first reported a position in PACB in Q1 2021 and held it in 14 quarters. The position peaked at $117K in Q1 2023. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2024.

  • Leonteq Securities AG reported no remaining Pacific Biosciences position as of Q3 2024 after selling out during the quarter.
  • Leonteq Securities AG sold 644 Pacific Biosciences shares in Q3 2024, an estimated $882.
  • Leonteq Securities AG first reported a position in Pacific Biosciences in Q1 2021 and held it in 14 quarters.
  • Leonteq Securities AG's Pacific Biosciences position peaked at $117K in Q1 2023.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2024.

Based on Leonteq Securities AG's 13F filing for Q3 2024, filed 4 Mar 2026.